Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 1
2018 1
2020 3
2021 3
2023 4
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Characterization of antibody response in neuroinvasive infection caused by Toscana virus.
Pierro A, Ficarelli S, Ayhan N, Morini S, Raumer L, Bartoletti M, Mastroianni A, Prati F, Schivazappa S, Cenni P, Vocale C, Rossini G, Gaibani P, Sambri V, Landini MP, Lewis RE, Charrel RN, Varani S. Pierro A, et al. Among authors: raumer l. Clin Microbiol Infect. 2017 Nov;23(11):868-873. doi: 10.1016/j.cmi.2017.03.017. Epub 2017 Mar 23. Clin Microbiol Infect. 2017. PMID: 28344163 Free article.
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, Fornaro G, Tonetti T, Pizzilli G, Francalanci E, Giuntoli L, Rubin A, Moroni A, Ambretti S, Trapani F, Vatamanu O, Ranieri VM, Castelli A, Baiocchi M, Lewis R, Giannella M, Viale P; PREDICO Study Group. Bartoletti M, et al. Clin Infect Dis. 2021 Dec 6;73(11):e3606-e3614. doi: 10.1093/cid/ciaa1065. Clin Infect Dis. 2021. PMID: 32719848 Free PMC article.
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
Chiereghin A, Zagari RM, Galli S, Moroni A, Gabrielli L, Venturoli S, Bon I, Rossini G, Saracino IM, Pavoni M, Lafratta S, Deni A, Felici S, Borghi M, Guerra L, Raumer L, Lodi V, Viale P, Attard L, Lazzarotto T; IRCCS St. Orsola Polyclinic of Bologna COVID-19 Research Team. Chiereghin A, et al. Among authors: raumer l. Front Public Health. 2021 Feb 18;8:620222. doi: 10.3389/fpubh.2020.620222. eCollection 2020. Front Public Health. 2021. PMID: 33681115 Free PMC article.
Carbapenem-Resistant Acinetobacter spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic.
Giannella M, Verardi S, Karas A, Abdel Hadi H, Dupont H, Soriano A, Santerre Henriksen A, Cooper A, Falcone M; ARES Study Group. Giannella M, et al. Open Forum Infect Dis. 2023 Jul 4;10(7):ofad329. doi: 10.1093/ofid/ofad329. eCollection 2023 Jul. Open Forum Infect Dis. 2023. PMID: 37496600 Free PMC article.
Exploring heterogeneity in antibiotic choices for bloodstream infections caused by AmpC-producing enterobacterales: results from a case-vignette study.
Tebano G, Campoli C, Meschiari M, Contadini I, Grasselli S, Lazzaretti C, Maritati M, Raumer L, Rinaldi M, Rossi N, Scolz K, Vanino E, Mussini C, Viale P, Cristini F. Tebano G, et al. Among authors: raumer l. Eur J Clin Microbiol Infect Dis. 2025 Oct 4. doi: 10.1007/s10096-025-05293-4. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2025. PMID: 41045445
14 results